Postcode lottery for UK heart failure patients, researchers find

Postcode lottery for UK heart failure patients, researchers find

Postcode lottery for UK heart failure patients: 15% of NHS units dedicated to treating the killer co...
read more
Analyzing a protein from cerebrospinal fluid will help diagnose patients with prion diseases

Analyzing a protein from cerebrospinal fluid will help diagnose patients with prion diseases

Every year in Catalonia 15 new cases of Creutzfeld...
read more
Guidance updated for sedation in pediatric dental patients

Guidance updated for sedation in pediatric dental patients

(HealthDay)—In conjunction with the American Aca...
read more
Cancer drug approved for NHS use in England gives some multiple myeloma patients another option

Cancer drug approved for NHS use in England gives some multiple myeloma patients another option

A drug has been made available on the NHS in Engla...
read more
Prostate cancer patients with gene mutation at three times the risk of dying

Prostate cancer patients with gene mutation at three times the risk of dying

Scientists have identified a gene mutation in the ...
read more
New model improves staging and risk predictions for esophageal cancer patients

New model improves staging and risk predictions for esophageal cancer patients

Esophageal cancer patients with positive lymph nod...
read more
Researchers discover how to prevent kidney damage in patients with multiple myeloma

Researchers discover how to prevent kidney damage in patients with multiple myeloma

Researchers at the University of Alabama at Birmin...
read more
Itchy skin affects the health and quality of life of many patients with kidney disease

Itchy skin affects the health and quality of life of many patients with kidney disease

New research reveals that pruritus, or itchy skin,...
read more
Children aged NINE damaged by Cannabis

Children aged NINE damaged by Cannabis

Children aged NINE damaged by Cannabis: Shocking t...
read more
Urovant Sciences Announces Positive Topline Results from Pivotal Phase 3 EMPOWUR Study of Vibegron in Patients with Overactive Bladder

Urovant Sciences Announces Positive Topline Results from Pivotal Phase 3 EMPOWUR Study of Vibegron in Patients with Overactive Bladder

IRVINE, Calif. & BASEL, Switzerland–(BUS...
read more
1 2 3